Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorval

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Cancer|April 15, 1984
Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapyD Machover, H Rappaport, L Schwarzenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Presse Medicale (Paris, France : 1983)|February 16, 1991
[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors]T Tursz, T Dorval, P Berthaud, et al.
British Journal of Cancer|February 1, 1994
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancerS M Scholl, C H Bascou, V Mosseri, et al.
Gynecologic Oncology|January 1, 1996
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II studyJ Y Pierga, V Dieras, D Paraiso, et al.
Cancer Investigation|January 1, 1996
Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancerE Raymond, T Palangie, M Jouve, et al.
The Journal of Infusional Chemotherapy|January 1, 1996
Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancerT Dorval, C Soussain, P Beuzeboc, et al.
Biotechnology Therapeutics|January 1, 1992
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parametersT Dorval, C Mathiot, O Chosidow, et al.
Cancer|March 27, 2001
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapyJ Y Pierga, B Asselain, M Jouve, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Is primary chemotherapy useful for all patients with primary invasive breast cancer?S M Scholl, P Beuzeboc, A L Harris, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Cancer|April 15, 1984
Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapyD Machover, H Rappaport, L Schwarzenberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemiaD Machover, J Gastiaburu, M Delgado, et al.
Presse Medicale (Paris, France : 1983)|February 16, 1991
[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors]T Tursz, T Dorval, P Berthaud, et al.
British Journal of Cancer|February 1, 1994
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancerS M Scholl, C H Bascou, V Mosseri, et al.
Gynecologic Oncology|January 1, 1996
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II studyJ Y Pierga, V Dieras, D Paraiso, et al.
Cancer Investigation|January 1, 1996
Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancerE Raymond, T Palangie, M Jouve, et al.
The Journal of Infusional Chemotherapy|January 1, 1996
Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancerT Dorval, C Soussain, P Beuzeboc, et al.
Biotechnology Therapeutics|January 1, 1992
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parametersT Dorval, C Mathiot, O Chosidow, et al.
Cancer|March 27, 2001
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapyJ Y Pierga, B Asselain, M Jouve, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Is primary chemotherapy useful for all patients with primary invasive breast cancer?S M Scholl, P Beuzeboc, A L Harris, et al.
Pageof 11